<DOC>
	<DOCNO>NCT02898168</DOCNO>
	<brief_summary>Among sequelae stroke , gait disorder directly link degree autonomy daily life patient . It consider significant effect Quality Life ( QOL ) . Further method rehabilitation require convalescent patient recover function soon well , due multitude recovery patient trouble gait problem . This trial study investigate effect gait train functional electrical stimulation ( FES ) ` WalkAide [ R ] ( WA ) ' improve lower-limb function ambulation convalescent stroke patient .</brief_summary>
	<brief_title>The Therapeutic Effects Peroneal Nerve Functional Electric Stimulation Lower Extremity Patients With Sub-acute Post-stroke Hemiplegia</brief_title>
	<detailed_description>This study target convalescent patient within 6 month onset initial stroke ( cerebral infarction cerebral hemorrhage ) also observe foot drop walking . Some study patient onset stroke ( several month ) report case efficacy treatment use FES , another case use FES indicate equal efficacy high QOL compare use ankle-foot orthosis ( AFO ) . However , clinical research result overseas many study target convalescent stroke patient . FES recover lose function paralysis use electrical stimulation recommend convalescent rehabilitation Japanese Guidelines Management Stroke 2015 etc.. The purpose FES treatment electrical stimulation peroneal nerve patient foot drop equinus foot due central nervous system damage objective efficacy follow : - To improve walk dorsiflexing foot swing phase - To prevention suppression disuse atrophy - To increase local blood flow - To re-educate muscle - To maintain increase range joint motion</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hemiplegia</mesh_term>
	<criteria>1 ) Patients agree participate study provide informed consent 2 ) Patients 20 85 year old time consent 3 ) Patients convalescent stoke ( within 6 month onset ) 4 ) Patients first episode stroke , type limit intracranial hemorrhage ischemic stroke ( exclude subarachnoid hemorrhage ) 5 ) Patients inpatient rehabilitation therapy 6 ) Patients diagnose 3 4 Functional Ambulation Classification ( FAC ) 7 ) Patients stable general condition ( blood pressure , pulse , blood glucose level etc . ) 8 ) Patients drop foot walk 1 ) Patients due severe heart disease 2 ) Patients previous gait disability , neurological disease 3 ) Patients previous orthopedic disease , knee osteoarthritis 4 ) Patients severe hepatic renal dysfunction 5 ) Patients severe sensory disturbance severe ataxia severe high brain dysfunction 6 ) Patients correspond contraindicate electrical stimulation ( e.g . patient medical implant implantable medical electrical equipment cardiac pacemaker ) 7 ) Patients severe skin disease 8 ) Patients dose adjustment antispasticity drug ( tizanidine hydrochloride , eperisone hydrochloride , baclofen , etc . ) within 1month 9 ) Patients whose impairment severity change study period 10 ) Patients take botulinum toxin formulation injection nerve block injection phenol within 6months 11 ) Patients low limb treatment use FES robot suit within 1month 12 ) Patients diagnose use WA trial operation period 13 ) Patients complete WA trial operation 7 day 14 ) Patients join clinical trial study intervention</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>Rehabilitation</keyword>
	<keyword>WalkAide ( WA )</keyword>
	<keyword>Functional Electrical Stimulation ( FES )</keyword>
</DOC>